u/formulary_fighter

Disagree — that figure is from the diabetes programme and you are quoting it as an obesity endpoint.

Plan and policy numbers redacted from the screenshot above.

Compounded preparations are not approved products and carry no bioequivalence claim. That is a statement about regulatory category, not about quality.

Left up. It describes an arrangement with specifics and it is honest about the jurisdiction.

the structural similarity is that both systems ration by friction rather than by rule, and friction is invisible in the published criteria.

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

lean mass loss during weight loss is expected, the question is how much

Left up. It describes an arrangement with specifics and it is honest about the jurisdiction.

Asked the supplier what documentation travels with the shipment and got a straight answer. That was reassuring in itself.

Agreed on potency testing of the finished preparation. That is a different question from the purity of the starting material.

Left up. It carries dates, a criterion and an outcome, which is what makes these threads useful.

Correcting myself upthread: the guidance I quoted was superseded last year.

Agreed on potency testing of the finished preparation. That is a different question from the purity of the starting material.

Who is the prescriber, and are they the same organisation as the pharmacy?

Disagreeing with this bit: registration is not equivalence, and the two get run together constantly.

Spent an evening on the receptor distribution literature and the side-effect map suddenly stopped looking random.

Added a jurisdiction tag — the answers differ completely between countries and plan types.

That is not what patient-specific means. It refers to the prescription, not to a customisation of the formula.

A log is a record of what you did. It is not a protocol, and posting one as a schedule for other members is a different thing that this board does not do.

The four columns that survive, after several people here have tried and abandoned much more elaborate systems.

Date. Dose. One number measured under consistent conditions. A short note when anything unusual happened. That is it. Anything more and you will stop, and a log you stop keeping is worth less than a crude one you maintain.

Add a waist measurement monthly if you can be bothered, and a sleep column if you want the one variable that explains the most confusing weeks. Everything else can be reconstructed from those, and nothing can be reconstructed from a log you abandoned in week nine.

incretin effect first, then everything else in this board makes sense

Not convinced. A rejected claim at the counter is not a denied authorization and the next step differs.

Some lean mass loss accompanies weight loss in any deficit. Resistance training and adequate protein intake are the two interventions with the best evidence for limiting the proportion.

prior authorisation criteria change every plan year

the less-tested the compound, the more the identity test matters

A denial letter is required to state a reason and to reference the criterion applied. That reference is the handle: request the clinical policy document by its identifier and answer it point by point.

The discontinuation numbers were the most useful thing in the paper for me and they were in a supplementary table.

Yes. Written, always, even when they tell you a phone call is sufficient.

Left up. It carries dates, a criterion and an outcome, which is what makes these threads useful.

Province added to the title. Coverage is provincial and the thread could not be answered without it.

Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.

Pharmacy staff name removed. The pharmacy can stay in a pricing post.

Why step therapy denials feel unfair and are nonetheless beatable.

The requirement is that documented trials of preferred alternatives exist. It is a record-keeping standard, not a clinical judgement about you, which is why arguing the clinical merits rarely moves it and producing dates and durations often does.

What to assemble: what was tried, at what dose, for how long, and what the documented outcome was. A one-page table with dates beats three pages of prose every time. Where a trial is contraindicated rather than simply unsuccessful, that needs to be stated explicitly by the prescriber in those terms.

None of this is legal or medical advice — it is what the threads here have found works.

Added a jurisdiction tag — the answers differ completely between countries and plan types.

potency testing on the finished preparation is the thing to ask for

Yes — a hold and a seizure are different events with different processes, and this board mixes them weekly.

gastric emptying slows, it does not stop

Added a jurisdiction tag — the answers differ completely between countries and plan types.

GIP is the arm people argue about because the biology is genuinely unsettled

jurisdiction first, everything else is downstream

Read a press release and the publication three months apart. The hedging in the second one was substantial.